CHARLESTON, SC, Leukogene Therapeutics, a biopharmaceutical company, announced that it has received funding.
Leukogene Therapeutics, a biopharmaceutical company developing next-generation therapies for hematologic and other immunologically 'cold' malignancies, announced that it has received funding from the South Carolina Research Authority (SCRA) and its investment affiliate, SC Launch Inc.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
